Table 4 Treatment-emergent adverse events by age group†
N (%) | |||
|---|---|---|---|
Event | Age 18 – 64 (n = 1178) | Age ≥ 65 (n = 101) | p-Value |
Nausea | 406 (34.5) | 29 (28.7) | .274 |
Insomnia | 378 (32.1) | 22 (21.8) | .034 |
Headache | 373 (31.7) | 16 (15.8) | <.001 |
Somnolence | 358 (30.4) | 23 (22.8) | .114 |
Dry mouth | 282 (23.9) | 18 (17.8) | .180 |
Dizziness | 267 (22. 7) | 31 (30.7) | .085 |
Constipation | 250 (21.2) | 23 (22.8) | .705 |
Increased sweating | 177 (15.0) | 15 (14.9) | 1.00 |
Anxiety | 176 (14.9) | 10 (9.9) | .188 |
Diarrhea | 157 (13.3) | 17 (16.8) | .363 |
Fatigue | 125 (10.6) | 9 (8.9) | .735 |